key: cord-0712974-4w74toot
authors: Castelli, Erick C.; de Castro, Mateus V.; Naslavsky, Michel S.; Scliar, Marilia O.; Silva, Nayane S. B.; Andrade, Heloisa S.; Souza, Andreia S.; Pereira, Raphaela N.; Castro, Camila F. B.; Mendes-Junior, Celso T.; Meyer, Diogo; Nunes, Kelly; Matos, Larissa R. B.; Silva, Monize V. R.; Wang, Jaqueline Y. T.; Esposito, Joyce; Coria, Vivian R.; Bortolin, Raul H.; Hirata, Mario H.; Magawa, Jhosiene Y.; Cunha-Neto, Edecio; Coelho, Verônica; Santos, Keity S.; Marin, Maria Lucia C.; Kalil, Jorge; Mitne-Neto, Miguel; Maciel, Rui M. B.; Passos-Bueno, Maria Rita; Zatz, Mayana
title: MHC Variants Associated With Symptomatic Versus Asymptomatic SARS-CoV-2 Infection in Highly Exposed Individuals
date: 2021-09-28
journal: Front Immunol
DOI: 10.3389/fimmu.2021.742881
sha: 1e382fd25bf1954d75593cdfdc7b802559f16b69
doc_id: 712974
cord_uid: 4w74toot

Despite the high number of individuals infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who develop coronavirus disease 2019 (COVID-19) symptoms worldwide, many exposed individuals remain asymptomatic and/or uninfected and seronegative. This could be explained by a combination of environmental (exposure), immunological (previous infection), epigenetic, and genetic factors. Aiming to identify genetic factors involved in immune response in symptomatic COVID-19 as compared to asymptomatic exposed individuals, we analyzed 83 Brazilian couples where one individual was infected and symptomatic while the partner remained asymptomatic and serum-negative for at least 6 months despite sharing the same bedroom during the infection. We refer to these as “discordant couples”. We performed whole-exome sequencing followed by a state-of-the-art method to call genotypes and haplotypes across the highly polymorphic major histocompatibility complex (MHC) region. The discordant partners had comparable ages and genetic ancestry, but women were overrepresented (65%) in the asymptomatic group. In the antigen-presentation pathway, we observed an association between HLA-DRB1 alleles encoding Lys at residue 71 (mostly DRB1*03:01 and DRB1*04:01) and DOB*01:02 with symptomatic infections and HLA-A alleles encoding 144Q/151R with asymptomatic seronegative women. Among the genes related to immune modulation, we detected variants in MICA and MICB associated with symptomatic infections. These variants are related to higher expression of soluble MICA and low expression of MICB. Thus, quantitative differences in these molecules that modulate natural killer (NK) activity could contribute to susceptibility to COVID-19 by downregulating NK cell cytotoxic activity in infected individuals but not in the asymptomatic partners.

Despite the high number of individuals infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who develop coronavirus disease 2019 (COVID- 19) symptoms worldwide, many exposed individuals remain asymptomatic and/or uninfected and seronegative. This could be explained by a combination of environmental (exposure), immunological (previous infection), epigenetic, and genetic factors. Aiming to identify genetic factors involved in immune response in symptomatic COVID-19 as compared to asymptomatic exposed individuals, we analyzed 83 Brazilian couples where one individual was infected and symptomatic while the partner remained asymptomatic and serum-negative for at least 6 months despite sharing the same bedroom during the infection. We refer to these as "discordant couples". We performed whole-exome sequencing followed by a state-of-the-art method to call genotypes and haplotypes across the highly polymorphic major histocompatibility complex (MHC) region. The discordant partners had comparable ages and genetic ancestry, but women were overrepresented (65%) in the asymptomatic group. In the antigen-presentation pathway, we observed an association between HLA-DRB1 alleles encoding Lys at residue 71 (mostly DRB1*03:01 and DRB1*04:01) and DOB*01:02 with symptomatic infections and HLA-A alleles encoding 144Q/151R with asymptomatic seronegative women. Among the genes related to immune modulation, we detected

Coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, became a worldwide pandemic affecting millions of people and the leading cause of death in Brazil in 2020 and 2021. Clinical manifestations range from severe cases with a lethal outcome to mild forms or asymptomatic cases. About 35%-50% of infected individuals are asymptomatic (1, 2) and are believed to be responsible for about 60% of transmissions (3) .

Investigations on COVID-19 in thousands of samples from worldwide populations demonstrated the role of host genetics in disease susceptibility. Some variants and specific genome regions are related to disease severity and hospitalization (a proxy for disease severity), with different genome-wide association studies (GWASs) pointing to similar results. Among these associated regions and variants, we may cite rs11385942 at 3p21.31, in the region encompassing genes SLC6A20, LZTFL1, CCR9, FYCO1, CXCR6, and XCR1, rs657152 at 9q34.2 (the ABO blood group), rs10735079 at 12q24. 13 , in a gene cluster that encodes antiviral restriction enzyme activators (OAS1, OAS2, and OAS3), and rs74956615 at 19p13.2 (gene TYK2). There is also rs2109069 at 19p13.3 within the gene that encodes dipeptidyl peptidase 9 (DPP9) and rs2236757 at 21q22.1 in the interferon receptor gene IFNAR2 (4-7). One GWAS detected hits within the major histocompatibility complex (MHC), rs9380142 (HLA-G) and rs143334147 (CCHCR1) (5) . However, while all these reported associations present p-values below the GWAS threshold (p < 10 -8 ), the odds ratios (ORs) are very low (usually less than 1.5), and they cannot be considered predictive genomic markers of disease severity. Since many genes influence COVID-19 severity, polygenic risk must be considered. Major efforts have been made to evaluate polymorphism and disease severity, usually by comparing hospitalized patients with a population-based sample (the normal control), but they do not evaluate COVID-19 resistance in exposed individuals.

Identifying asymptomatic individuals or those resistant to the infection who are seronegative even after high exposure is challenging, since controlling for and measuring different degrees of exposure are complex. Asymptomatic or resistant individuals, however, may provide clues on the mechanisms of resistance and infection itself.

Genes modulating immune responses are natural candidates in studying resistance to infectious agents and disease outcomes. Together with other genomic regions, as the ones listed earlier, they may contribute to the "resistant' phenotype. It has been shown that both innate and adaptive immune responses are crucial in the fight against COVID- 19 (8, 9) . In this context, the human MHC, harboring genes related to antigen processing, presentation, and immune modulation (10) , is critical for both adaptive and innate immune responses. The human leukocyte antigen (HLA) genes within the MHC are among the most polymorphic genes in the human genome, and they are important targets for natural selection (11) . The HLA class I molecules present antigens to CD8+ T lymphocytes (e.g., HLA-A, HLA-B, and HLA-C, usually expressed in all somatic cells) and HLA-class II to CD4+ T lymphocytes (e.g., HLA-DRB1, HLA-DQA1 and -DQB1, HLA-DPB1, and others, usually expressed on professional antigen presentation cells, but also in activated T lymphocytes). In addition, HLA molecules play a critical role in the modulation of NK cell activity (e.g., HLA-C, HLA-G, HLA-E, and HLA-F, with a more restricted expression profile) (12) . The MHC also harbors genes involved in antigen processing and loading (HLA-DOA, HLA-DOB, HLA-DMA, HLA-DMB, TAP1, and TAP2), cytokines such as tumor necrosis factor (TNF) and complement components, and genes that modulate the activity of NK cells, as MICA and MICB. The expression of MICA and MICB is low in normal tissues but is induced in tumors or during infections, upregulating (when expressed in the membrane) or downregulating (when expressed as soluble isoforms) NK cell cytotoxic activity (13) .

Because of their unusually high polymorphism and extensive paralogy, GWAS findings for genes from the MHC are often ignored or treated with caution, as a consequence of HLA allele frequencies varied markedly across the world, and there may be different associations for different populations with diverse ethnicities. Because of that, the few studies on the frequency and distribution of HLA alleles and their clinical relevance for the SARS-CoV-2 infection (14-17) have shown conflicting results. However, the HLA locus is among the top hits in one GWAS from the COVID-19 Host Genetics Initiative (6) .

To identify genetic factors involved as key players in the immune response of symptomatic SARS-CoV-2 infection and resistance, we have analyzed a cohort of couples discordant for the infection. While one was infected with symptomatic disease, the household-sharing partner, despite being closely exposed during the infection period, remained asymptomatic and seronegative for SARS-CoV-2 up to 6 months after the putative exposure. We whole-exome sequenced these couples, applied a bioinformatics pipeline to properly analyze variants within the MHC, and tested for genetic associations with disease/ resistance phenotypes. 

Initial recruitment for screening involved broad media advertising based on the main inclusion criteria: couples discordant for SARS-CoV-2 symptomatic infection. From more than 2,000 received emails, we recruited 100 couples, all from São Paulo city (Brazil's most populated metropolis). All couples filled out an online questionnaire, which included basic personal information (age, sex, blood type, comorbidities), and clinical progression of COVID-19 as well as diagnostic tests. The asymptomatic and seronegative member remained in close contact with his/her symptomatic partner throughout the SARS-CoV-2 infection, sharing the same bed (except when the symptomatic one needed to be hospitalized). Confirmatory tests (RT-PCR for symptomatic and RT-PCR or serology for asymptomatic) endorsed that just one of the pair had symptomatic viral infection at the time and that all asymptomatic are seronegative. The collection of biological samples occurred at intervals from 30 to 180 days after the reported viral infection. Serological testing was repeated in the blood plasma with two different techniques (electrochemiluminescence and ELISA-SARS-CoV-2 RBD/NP IgA and IgG). This excluded seven couples where the asymptomatic partner was found to have IgA or IgG antibodies against SARS-CoV-2. After exome sequencing quality control, we obtained data on 83 couples. To provide a baseline of allelic diversity and frequency, we also compared the exposed asymptomatic seronegative (the COVID-19[-] group) and the symptomatic group (the COVID-19[+] group) with MHC data from a previously whole-genome sequenced census-based sample of elderly individuals from the same city, pairing samples by gender and genetic ancestry (18) . The characteristics of each group are available in Supplementary Table S1 . Notably, the samples were collected between June and October 2020, before new SARS-CoV-2 variants were reported in Brazil (especially Gamma).

The dataset is composed of couples sharing the same household and bedroom during the infection of one individual (Supplementary Figure S1 ). Three comparisons were conducted. 

We used the Nextera Rapid Capture Custom Enrichment Kit or the Nextera Flex Kit (Illumina, San Diego, CA, USA) for library preparation and the IDT xgen-V1 kit for capture following manufacturer protocols. Whole-exome sequencing was performed on the NovaSeq 6000 equipment (Illumina, USA) with a 150-base paired-end dual index read format. Reads were aligned to the human reference GRCh38 using Burrow-Wheeler Aligner (BWA) (https://github.com/lh3/bwa/tree/master/bwakit). We also called genotypes using GATK HaplotypeCaller (version 4.0.9). The pipeline used for alignment, variant calling, variant refinement, and genetic ancestry assessment is detailed in the supplementary methods.

Genes from the MHC are prone to alignment bias and genotyping errors because of the significant similarity and high polymorphism. To circumvent this issue, we used hla-mapper version 4 (19) to optimize read alignment for specific genes from the MHC (Figure 1 ), as described elsewhere (18, 19) . After applying hla-mapper, we called genotypes using GATK HaplotypeCaller with a further refinement step using vcfx.

To obtain phased variants for each gene, we first phased close variants using GATK ReadBackedPhasing and then analyzed phase sets using the phasex program (https://github.com/erickcastelli/ phasex), as described previously for a large Brazilian sample (18) .

After the hla-mapper optimization and phasing, we obtained the complete exonic sequences for each individual and the translation of these sequences (Supplementary Figure S2) . These methods are detailed in the supplementary methods, including the procedure to call HLA alleles.

Associations of phenotypic status with biallelic and multiallelic variants, allotypes, and specific amino acids were tested by fitting a logistic regression that considers each allele of a variant as an independent marker, controlling for age, genetic ancestry (all comparisons), and sex (when not stratifying by sex] using a local Perl script to convert the Variant Call Format (VCF) data into a plink-like table and R to fit the logistic regression. Due to sample size limitations, likely multifactorial inheritance, and the high number of variable sites (many multiallelic) in the MHC, we did not expect large effect sizes to be detected. Therefore, we used the threshold (p < 0.005) to detect candidates that may influence symptomatic infection susceptibility. To test if rare variants of larger effects contribute to the outcome, we also performed genebased variant collapsing tests using SKAT-O within the rvtest program (20) , enabling the analysis of multiallelic variants. SKAT-O is an optimized method for rare variants that combines and compares burden and SKAT tests, resulting in an optimal p-value for a given variant set (gene or gene set), controlling for the same covariates as individual variant associations.

We first compared the COVID-19 [-] and COVID-19[+] groups, controlling for age, sex, and genetic ancestry (Comparison 1, Supplementary Figure S2 ). These groups had comparable ages, socioeconomic status, and genetic ancestry proportions (Supplementary Table S1 ). We observed a large sex difference between the two groups; 51 men and 32 women among symptomatic individuals compared to 29 males and 54 females among COVID-19 [-] . Because some variants might be linked to symptomatic infection only in men or women, we also stratified the groups by sex (21) in comparisons 2 and 3 (Supplementary Figure S2 ). In all cases, for each group, we selected a populationbased sample paired by sex and genetic ancestry to compare the frequencies with the expected in the general population.

Among 1,723 queried variants within the genes illustrated in Figure 1 , 13 attained significance at the p < 0.005 threshold ( Figure 2 ). When controlling for sex, we found candidate variants for MICA, MICB, HLA-DRB1, HLA-DOB, and HLA-DPB1 genes ( Figure 2 We applied SKAT-O in each candidate gene to evaluate the contribution of rare and common variants collapsed into gene-wide sets. Among MHC genes, we identified a significant association between MICB and COVID-19[+] (p = 0.017). We verified that the association signal was driven by the same common variants identified by the single variant association test described in Figure 2 .

Most of the candidate variants in Figure 2 To investigate how specific protein sequences or amino acid residues may influence susceptibility to SARS-CoV-2 symptomatic infection, we translated all the exonic sequences to proteins, in silico, comparing the frequency of every full-length protein (the allotypes) and every amino acid residue between groups (Figure 3) . When stratifying the groups by sex, the HLA-A residues 168Q and 175R, both corresponding to HLA-A missense mutations listed in Figure 2 , are underrepresented in symptomatic men (p < 0.005) compared to COVID-19 [-] women and in the general population (p < 0.05). However, we do not observe these differences when comparing COVID-19[+] and COVID-19 [-] with the same sex (Supplementary Figure S4) . HLA-DOB*01:02 is overrepresented mostly in COVID-19[+] women (p = 0.0044, OR = 9.0678). Overall, the protein and amino acid analyses corroborate what was observed in the single-nucleotide polymorphism (SNP) analysis for missense mutations.

We also tested HLA-A and HLA-B alleles grouped as supertypes (22) . There is a trend to lower frequency of supertype A03 among exposed seronegative (p = 0.0378) when controlling for genetic ancestry, sex, and age, but this association was not significant after correction for multiple tests (six different HLA-A supertypes) or when stratifying samples by sex (Supplementary Table S2) .

Finally, we discussed potential mechanisms underlying the associations presented in Figures 2, 3 (detailed at the Supplementary Results). In brief, the promoter variant from MICA is associated with higher mRNA expression levels (Supplementary Figure S5) . In comparison, the susceptibility variants for MICB are associated with lower mRNA expression (Supplementary Figure S6) . The susceptibility variant from HLA-DOB modifies the signal peptide and possibly the cellular localization and trafficking of the protein. The female HLA-A protective variants do not influence HLA-A expression levels.

Environmental factors such as protective measures, socioeconomic status, and access to healthcare may explain in part the high variability in COVID-19 disease incidence and (23)]. GWASs addressing COVID-19 severity detected many different genomic regions and specific variants influencing the disease outcome (4-7, 24). However, it became clear that polygenic risk must be considered, since the ORs of these associations are relatively underpowered, usually lower than 1.5. The Brazilian media reported that both sibs from seven pairs of monozygotic adult twins died from SARS-CoV-2 infection within a few days of difference. Furthermore, recent observations showed that secondary transmission among close household contacts was 53% (25) . These observations support the influence of host genetics in COVID-19 severity and resistance (6) , particularly in a polygenic fashion.

An efficient response in the early course of SARS-CoV-2 infection may strongly influence infection outcome, differentiating CODIV-19-unaffected resistant individuals or asymptomatic after exposure and symptomatic ones. Several studies aimed to understand the human genetics of protective immunity to SARS-CoV-2 (24, 26, 27) . Innate immune genes and genes involved in antigen presentation seem to be strong candidates in this matter, contributing with an additional layer to other known genomic regions that influence COVID-19 outcome (4-7, 24).

Spouses of infected and symptomatic COVID-19 patients (COVID-19[+]) sharing the same bedroom without protective measures represent an efficient approach to identify and ascertain resistant individuals highly exposed to the same viral strain of SARS-CoV-2. Here, we investigated 83 discordant couples, in which one was symptomatic and the partner remained asymptomatic and seronegative for at least 6 months. Since we collected all samples in the first semester of 2020, all couples were likely exposed to the same or closely related viral strains (28) . Our study suggests that genes of innate and adaptive immune responses may play a vital role in susceptibility/ protection to symptomatic SARS-CoV-2 infection. The innate response is key for controlling primary encounters with a pathogen (29) . In the case of COVID-19, although SARS-CoV-2 is a novel pathogen, it shares extensive CD4+ and CD8+ T-cell cross reactivity with human endemic coronaviruses (30-32) and would therefore elicit a secondary T-cell response to the crossreactive epitopes. This cross-reactive secondary T-cell response could eradicate SARS-CoV-2 infection in a proportion of individuals, even before a specific SARS-CoV-2 antibody response is made, as demonstrated in family contacts of COVID-19 patients (33, 34) .

MHC variants showed no important associations between class I antigen-presentation genes (HLA-A, HLA-B, and HLA-C) and nonclassical HLA class I genes (HLA-G, HLA-E, and HLA-F) in symptomatic infection susceptibility. The only exception is two missense mutations of HLA-A protecting mainly women when the male partner is symptomatic (rs1059517/C and rs1059536/G), both related to some common allotypes such as HLA-A*23:01, *29:02, *30:01, *30:02, *31:01, *32:01, and A*33:01 ( Figure 3) . None of these alleles present relevant frequency differences when considered alone, but most of them are overrepresented in COVID-19 [-] women, particularly HLA-A*23:01 and *29:02. These SNPs lead to two amino acid exchanges in the HLA-A molecule, encoding Q and R at residues 168 and 175 of the full protein (or 144 and 151 in the mature molecule), respectively. These residues belong to the alpha-2 domain, but they seem to not influence peptide binding (35) , although residue 175 can interact with the T-cell receptor. The binding prediction of SARS-CoV-2 peptides to HLA class I genes indicated that alleles A*23:01 and A*29:02 are intermediate binders, thus enhanced antigen presentation should not be the case (36) . Moreover, these variants seem to not influence HLA-A mRNA expression levels in men, women, or the combined sample. HLA-A*23:01 was detected as risk markers for severe COVID-19 among Spanish patients (37), but not in Russia (38) . A GWAS detected a trend to a higher frequency of A*23:01 among the general population than in severe COVID-19 Italian patients, but no differences for A*29:02 (4). A study from China comparing COVID-19 patients and the general population did not detect any HLA-A association (39) . Moreover, in our study, polymorphisms of nonclassical HLA genes involved in immune modulation (e.g., HLA-E) were not associated with symptomatic infection susceptibility in discordant couples, but a higher frequency of HLA-E*01:01 has been reported to be associated with hospitalized patients (9) . In addition, we cannot rule out the influence of HLA-G, particularly variant rs9380142 as described in a recent GWAS (5), because this is a 3'-untranslated region (UTR) variant not captured by our exome analysis. Previous studies focusing on HLA genes and SARS-CoV-2 infection, comparing infection outcome (mild vs. severe COVID- 19) or infection susceptibility in infected individuals against population control samples, show different associated alleles for each population and sample (4, 9, 14, 17, 38, 40) . This lack of consistency among studies possibly reflects the wide frequency differences of HLA alleles among populations and how each study characterized its samples.

For HLA class II genes, we found an association of K at residue 101 of HLA-DRB1 when considering the full-length molecule (or residue 71 in the mature protein) with symptomatic infection susceptibility, mostly related to increased frequencies of DRB1*03:01 and DRB1*04:01 among symptomatic patients (Figure 3) . HLA-DR molecules are important antigen-presenting molecules, essentially for CD4+ T cells, and lower HLA-DRB1 expression has been associated with the severity of the SARS-CoV-2 infection (41) . Thus, inappropriate antigen-presentation by some HLA-DR molecules might facilitate infection susceptibility. Accordingly, DRB1*04:01 has been associated with lower HLA-DRB1 mRNA expression than many other alleles (42) . Furthermore, these results conflict with previous data from other populations. For instance, in North East of England (43) and Saudi Arabia (44), HLA-DRB1*04:01 was 2-3 times more frequent in the asymptomatic group. Likewise, DRB1*03:01 had a protective effect against SARS-CoV-2 infection in the Sardinian population (40) . In our survey, HLA-DRB1*04:01 and DRB1*13:03 were six times and three times more frequent among symptomatic individuals (p = 0.0187 and p = 0.0229, respectively), and DRB1*03:01 was also more frequent among symptomatic individuals (individually not significant). Taken together, they contribute to the much higher frequency of residue 71K among symptomatic individuals than exposed seronegative ones (p = 0.0044), which was also confirmed by the comparison with the general population (p = 0.0066). DRB1*04:01 is common in European populations (France, Denmark, England, Germany) and relatively rare in Asian and African populations (www.allelefrequencies.net). Conversely, DRB1*03:01 is common in Europe and Africa but uncommon in East Asia. In our sample, Brazilians carrying DRB1*04:01 present a much higher East Asian genetic ancestry (10.7%) than observed in the entire dataset (around 1.5%), while Brazilians carrying DRB1*03:01 present a similar ancestry background than the entire dataset. This lack of consistency for HLA-DRB1 associations among populations is another example of population-specific associations.

The DOB*01:02 (rs2071554/T, a missense variation in the HLA-DOB signal peptide) may have a potential effect in protein function, since in silico analysis of functional effects of this variation predicted a possible damage to the protein function (45) . HLA-DO molecule is a modulator of HLA-DM, a peptide exchange factor required for efficient loading of endosomal peptides onto MHC-II molecules (46) . This may lead to inadequate antigen presentation failure to recognize important epitopes.

Interestingly, most of the MHC class I region hits coincide with two genes, MICA and MICB. MICA and MICB are constitutively expressed in a few cell types, such as fibroblasts and epithelial cells but are markedly upregulated in stress conditions like cancer and infections (47) . Here, the regulatory MICA variant associated with symptomatic infection is related to higher mRNA expression, possibly higher soluble MICA (sMICA), while the opposite is observed for all MICB variants (supplementary results). MICA and MICB interact with activating receptor C-type lectin-like receptor NKG2D and play an important role in mediating NK and TCD8+ cytotoxic activity (48) .

Previous studies suggest the participation of the unconventional T (uT) cells, gamma-delta T (gd T), NKT, and NK cells in the immune response against several infections such as tuberculosis, HIV, Influenza A, Influenza A (H1N1) [reviewed by (49) ], as well as SARS-CoV-1 (50) and SARS-CoV-2 infections (51) . These cells recognize non-peptide antigens in an MHC-independent way and produce mostly inflammatory cytokines such as interferon (IFN)-g and eliminate target cells by perforin/granzyme-mediated cytotoxicity in vivo (52) . Thus, these cells could be a key for a rapid defense against bacterial and viral infections (53) and contribute to control viral load through a higher MICB expression (from the exposed seronegative individuals), activating an effective natural response via NKG2D.

The missense MICB variant associated with SARS-CoV-2 symptomatic infection, MICB*004 and rs3131639/A, is clearly overrepresented in symptomatic patients compared to both exposed seronegative and the general population. Interestingly, its frequency is also increased in patients with secondary dengue hemorrhagic fever (54) . Thus, higher MICB expression may positively influence DENV infection control by activating early NKG2D-mediated immune responses. A similar mechanism may be important for SARS-CoV-2 infection, and higher MICB expression may play a role in the innate immune defense against SARS-CoV-2. Conversely, variants associated with lower MICB expression, possibly implicating a diminution of NK cytotoxicity, may facilitate infection. Besides, the amino acid exchange (75-N, Figure 3 ) may also be related to ligand/receptor binding impairment or lower protein stability. In our study, rs3131639/A and MICB*004 are related to lower MICB expression (Supplementary Figure S3) , which is confirmed by the GTEx portal (https://www.gtexportal.org). The mechanism underlying this differential expression or whether other polymorphisms in LD with rs3131639, particularly in the MICB promoter region, may also play a role in the expression regulation is not clear.

MICA alleles are also associated with susceptibility to infectious diseases (55) . Here, the MICA variant associated with symptomatic infection is linked to higher MICA mRNA expression (Supplementary Figure S2) . This variant is also in LD with MICA allotypes that associated with high levels of sMICA (56, 57) , MICA*008 and MICA*019, both overrepresented among symptomatic individuals. High levels of soluble sMICA would have an inverse effect on NK cell activation. Other viruses are known to stimulate the release of sMICA to escape NKG2D recognition by activating endocytosis and degradation of the NKG2D receptor (58) . A recent study suggested that dysregulation of the NKG2D-MICA axis could be a possible mechanism of NK cell exhaustion in SARS-CoV-2 infection, resulting in suppressive effects by excessive cytokines in the disease course. SARS-CoV-2 might escape from NKG2D recognition using a similar mechanism of elevated plasma levels of sMICA. For instance, the disintegrin and metalloproteinase17 (ADAM17) activity is upregulated upon binding of SARS-CoV to ACE2, facilitating viral entry. This might be responsible for the higher shedding of MICA after spike-ACE2 interaction during SARS-CoV-2 infection [reviewed by (59) ]. Although not confirmed by protein expression analysis, we can hypothesize that the variants associated with higher MICA expression are also associated with higher sMICA levels and/or NK exhaustion, resulting in NK dysfunction in the early stages of SARS-CoV-2 infection. Indeed, decreased NK cell numbers, impaired cytotoxic activity, and a biased inflammatory phenotype have been reported in SARS-CoV-2 infection, indicating that NK cells likely integrate into the underlying immune dysregulation in COVID-19. In addition, sMICA levels were considerably higher in COVID-19 patients with severe disease (60) . In this context, our findings bring additional potential mechanisms involving NK dysfunctions [reviewed by (61) ], which could be confirmed by functional assays.

Innate immunity efficiency may be a critical feature between symptomatic and asymptomatic infections, and it also may facilitate the prompt elimination of the virus after exposure. Host genetics influence this feature. For instance, inborn errors of TLR3-and IRF7-dependent type I IFN immunity are associated with life-threatening COVID-19 pneumonia (24), and neutralizing autoantibodies against IFN type I were detected in 10% of patients with life-threatening COVID-19 pneumonia (62) . These findings highlight the importance of the innate immunity against SARS-CoV-2. Here, we add another potential layer to this complexity-host genetics influencing NK cell activation efficiency due to differential expression capabilities of MICA and MICB.

The susceptibility haplotype formed by the MICB variants in Figure 2 is more frequent in Europe (about 23%) and Africa (15%) and less frequent in Asia (9.4%). Conversely, MICA allele rs2596541/C is more frequent in East Asia (about 72%), South Asia (about 63%), and Europe (about 60%) and less frequent in Africa (about 46%). Interestingly, the MICB susceptibility haplotype can be detected in archaic humans, such as the Neanderthal from the Vindija Cave, and the MICA susceptibility allele in the Neanderthal from the Altai Mountains and one Denisovan.

In short, here we performed a candidate region approach to compare polymorphisms in the MHC region in symptomatic COVID-19-infected individuals and in highly exposed partners who were seronegative. We used a state-of-the-art method to call genotypes and haplotypes in the MHC. We observed little to no impact of polymorphisms in class I antigen-presentation genes, except for HLA-A allotypes carrying 144Q and 151R among asymptomatic women when the male partner is symptomatic, increasing susceptibility to symptomatic infection. We also observed an association of HLA-DRB1 alleles encoding K at residue 71 (DRB1*03:01, DRB1*04:01, and others) with susceptibility to symptomatic infections. Allele HLA-DOB*01:02 is associated with symptomatic infection mostly among women. Moreover, our results suggest that genes related to immune modulation, mainly involved in NK cell killing activation/inhibition, harbor variants potentially contributing to infection resistance. We hypothesize that individuals prone to produce higher amounts of sMICA, and low amounts of MICB, would be more susceptible to symptomatic infections. Accordingly, quantitative differences in these NK activity-related molecules could contribute to susceptibility to COVID-19, likely downregulating NK cell cytotoxic activity in infected individuals but not in resistant partners. Functional assays will provide the means to test the hypothesis of differential NK cell activity between COVID-19 symptomatic and asymptomatic exposed individuals, involving MICA and MICB.

Host genetics influencing NK cell activation due to differential expression of MICA and MICB is another layer in the complex interaction between the human genome and COVID-19 outcome. The current knowledge regarding this matter supports the link between polymorphisms and susceptibility to life-threatening COVID-19, the majority promoting moderate-higher risk. The associations described here follow the same path but with slightly higher ORs than those described in previous GWASs (4) (5) (6) (7) . For instance, the OR for MICB*004 and HLA-DOB*01:02 for symptomatic infection is 2.8 and 7.39, respectively.

Due to the likely multifactorial nature of resistance itself, the putative resistant individuals in our study could be protected by NK cell response or cytotoxic effects present due to previous endemic coronavirus with common antigenic exposure to SARS-CoV-2 (cross reaction).

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

This study was approved by the Committee for Ethics in Research of the Institute of Biosciences at the University of São Paulo (CAAE 34786620.2.0000.5464). The patients/participants provided their written informed consent to participate in this study. 

Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review

Asymptomatic SARS-CoV-2 Carriers: A Systematic Review and Meta-Analysis

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Genomewide Association Study of Severe Covid-19 With Respiratory Failure

Genetic Mechanisms of Critical Illness in COVID-19

Covid-19 Host Genetics Initiative Authors. Mapping the Human Genetic Architecture of COVID-19

Integrative Genomic Analyses Identify Susceptibility Genes Underlying COVID-19 Hospitalization

Adaptive Immunity to SARS-CoV-2 and COVID-19

Puchhammer-Stöckl E. Deletion of the NKG2C Receptor Encoding KLRC2 Gene and HLA-E Variants are Risk Factors for Severe COVID-19

Gene Map of the Extended Human MHC

First of Two Parts

Immunobiology of Human NKG2D and its Ligands

Possible Role of HLA Class-I Genotype in SARS-CoV-2 Infection and Progression: A Pilot Study in a Cohort of Covid-19 Spanish Patients

Estimating the Binding of Sars-CoV-2 Peptides to HLA Class I in Human Subpopulations Using Artificial Neural Networks

Human Leukocyte Antigen Susceptibility Map for SARS-CoV-2

HLA Allele Frequencies and Susceptibility to COVID-19 in a Group of 99 Italian Patients

Whole-Genome Sequencing of 1,171 Elderly Admixed Individuals From the Largest Latin American Metropolis (São Paulo, Brazil)

Hla-Mapper: An Application to Optimize the Mapping of HLA Sequences Produced by Massively Parallel Sequencing Procedures

RVTESTS: An Efficient and Comprehensive Tool for Rare Variant Association Analysis Using Sequence Data

Sex Differences in Immune Responses

HLA Class I Supertypes: A Revised and Updated Classification

Molecular Diversity of Coronavirus Host Cell Entry Receptors

Inborn Errors of Type I IFN Immunity in Patients With Life-Threatening

Transmission of SARS-COV-2 Infections in Households -Tennessee and Wisconsin

Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation

A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection

Evolution and Epidemic Spread of SARS-CoV-2 in

COVID-19 and the Human Innate Immune System

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans With COVID-19 Disease and Unexposed Individuals

Selective and Cross-Reactive SARS-CoV-2 T Cell Epitopes in Unexposed Humans

Expected Immune Recognition of COVID-19 Virus by Memory From Earlier Infections With Common Coronaviruses in a Large Part of the World Population

Intrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response Without Seroconversion

Robust T Cell Immunity in Convalescent Individuals With Asymptomatic or Mild COVID-19

Zooming Into the Binding Groove of HLA Molecules: Which Positions and Which Substitutions Change Peptide Binding Most?

Binding Affinities of 438 HLA Proteins to Complete Proteomes of Seven Pandemic Viruses and Distributions of Strongest and Weakest HLA Peptide Binders in Populations Worldwide

Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease

Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19

Distribution of HLA Allele Frequencies in 82 Chinese Individuals With Coronavirus Disease-2019 (COVID-19)

Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course

Identification of Potential mRNA Panels for Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) Diagnosis and Treatment Using Microarray Dataset and

Capturing Differential Allele-Level Expression and Genotypes of All Classical HLA Loci and Haplotypes by a New Capture RNA-Seq Method

The Influence of HLA Genotype on the Severity of COVID-19 Infection

Frequency of HLA Alleles Among COVID-19 Infected Patients: Preliminary Data From Saudi Arabia

Inflammation-Related Genetic Variations and Survival in Patients With Advanced non-Small Cell Lung Cancer Receiving First-Line Chemotherapy

What to do With HLA-Do?

Regulation of Ligands for the NKG2D Activating Receptor

Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible

Protective Role of gd T Cells in Different Pathogen Infections and its Potential Clinical Application

Anti-Severe Acute Respiratory Syndrome Coronavirus Immune Responses: The Role Played by Vg9vd2 T Cells

More Bricks in the Wall Against SARS-CoV-2 Infection: Involvement of g9d2 T Cells

Tissue Specific Functions of Invariant NKT Cells

Mucosal-Associated Invariant T Cells and Disease

Major Histocompatibility Complex Class I Chain-Related A and B (MICA and MICB) Gene, Allele, and Haplotype Associations With Dengue Infections in Ethnic Thais

Functional MICA-129 Polymorphism and Serum Levels of Soluble MICA are Correlated With Ulcerative Colitis in Chinese Patients

Allele Specific Expression of MICA Variants in Human Fibroblasts Suggests a Pathogenic Mechanism

MICA*019 Allele and Soluble MICA as Biomarkers for Ankylosing Spondylitis in Taiwanese

Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma

Features of HLA Class I Expression and its Clinical Relevance in SARS-CoV-2: What do We Know So Far

Prognostic Value of Serum MICA Levels as a Marker of Severity in COVID-19 Patients. Preprint (2021) 1-10

Natural Killer Cell Dysfunction and its Role in Covid-19

Autoantibodies Against Type I IFNs in Patients With Life-Threatening

Conflict of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

The authors are extremely grateful to all volunteers for their participation and collaboration, the nurses for sample collection, the technical team for the material process and data analysis, and the Fleury Laboratory for serology tests. Special thanks to Brazilian Senator Mara Gabrilli for financial support and to JBS S.A. for the additional funding. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2021.742881/ full#supplementary-material